MEI Pharma Corp (MEIP) - Tingkat bathi reged

Simbol resmi perusahaan MEI Pharma Corp (MEIP)

MEI Pharma, Inc. (MEIP) minimizes risks by developing a range of molecules to combat various types of blood cancer. The gross profit margin relative to revenue is available on the GURU.Markets chart, where 0.00 serves as the current parameter value. The business is independent of economic cycles, and future pricing power relies on FDA decisions and the terms of scientific contracts.

meipharma.com - Margin reged MEIP (periode 04.07.2022 - 11.09.2025)

Rincian analitis lan laporan data perusahaan MEI Pharma, Inc. (MEIP)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis dhasar perusahaan:MEIP, MEI Pharma
Produk asil prodhuksi MEI Pharma Corporation

Gross margin measures production efficiency by determining the portion of revenue remaining after direct product creation costs. For MEI Pharma, Inc. (MEIP), the median gross margin reflects scaling potential: as a drug enters the global market, R&D costs stabilize while profits grow exponentially. The trend of this indicator allows investors to assess the business's resilience to crises and the risk of overpaying for the asset.